期刊文献+

老年人舒张性心力衰竭93例临床分析 被引量:1

下载PDF
导出
摘要 目的探讨老年人舒张性心力衰竭的临床特点。方法对93例老年舒张性心力衰竭患者的临床资料进行回顾性分析。结果93例患者中高血压39例,冠心病32例;劳力性呼吸困难93例,心悸81例,胸闷46例,咳嗽21例,两肺湿啰音47例,肺瘀血61例,心律失常发生率高,左室舒张末内径≤60 mm,射血分数均>50%。经治疗显效51例(54.8%),有效37例(39.8%),无效5例(5.4%),总有效率94.6%。结论老年人舒张性心力衰竭如能正确诊断和合理治疗,可显著改善心功能。
作者 隆海文
出处 《广西医学》 CAS 2009年第3期384-385,共2页 Guangxi Medical Journal
  • 相关文献

参考文献6

二级参考文献30

  • 1Tocehi D, Gazdic LP, Berman R, et al. Angiotensin Ⅱ receptor blockade combined to ACE inhibition improves ventricular dilation and exercise ejection fraction in congestive heart failure[J]. JACC, 1998,37(2) :391~398.
  • 2Adams MA, Trudeau L. Irbesartan: review of pharmacology and comparatives[J]. Can J Clin Pharmacol,2000,7(1) :22-31.
  • 3Rosendorff C. The renin-angiotensin system and vascular hypertrophy [J]. J Am Coll Cardiol, 1996,28:803-812.
  • 4Gillis JC, Markham A. Irbesartan: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the managemen to hypertension[J ]. Drugs, 1997,54:885-902.
  • 5Jacksou EK , Gerrison JC. Renin and angiotensin. In:Hardman JG ,Limbird LE, Moliroff PB, et al. The pharmacological basis of therapeutics. 9th eds. New York: McGraw Hill Ccnp, 1996. 733-758.
  • 6Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus nopropranolol on total mortality plus nonfatal myocardial infarction in older patient with prior myocardial infarction, congestive heart failure and left ventricular ejection fraction>40% treated with diuretics plus angiotensin-converting enzymeinhibitors inhibitors[J].AM J Cardiol, 1997,(80):207-209.
  • 7The Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure[J].N Engl J Med,1997,336:525-533.
  • 8Min Zi, Neil Camichael, Michael Lye. The effect of quinapril on functional status of elderly patients with diastolic heart failure[J].Cardiovasc. Drug. Ther, 2003,3(17):133.
  • 9Yusuf S,Pfeffer MA, Swedbery K,et al. Candesartan in heart failure assessment of reduction in mortality and morbidity[J].Lancet,2003,362:777-781.
  • 10Dahlf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol[J]. Lancet,2002,359:995-1003.

共引文献89

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部